NewsRx

Search our medical news database

Endometrial Cancer

Research Conducted at Duke University Has Updated Our Knowledge about Endometrial Cancer

Published in Women's Health Weekly, September 1st, 2011

2011 SEP 1 -- "The objective of the study was to compare adverse event rates between laparoscopic vs open surgery for endometrial cancer. This was a retrospective cohort study comparing 107 women who underwent laparoscopy with 269 age-and body mass index-matched women who underwent laparotomy for treatment of endometrial cancer," scientists in Durham, North Carolina report.

"Adverse event rates were similar between cohorts (37% laparoscopy vs 43% laparotomy, P = .248). Laparotomies had higher rates of cellulitis (16% vs 7%, P = .018) and open wound infection (9% vs 2%, P = .02), whereas laparoscopy had higher rates of sensory peripheral nerve deficit (5% vs...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook